1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Inogen, Inc.
  6. Summary
    INGN   US45780L1044

INOGEN, INC.

(INGN)
  Report
Real-time Estimate Cboe BZX  -  11:23 2022-08-12 am EDT
30.69 USD   +1.82%
08/04INOGEN : Q2 Earnings Snapshot
AQ
08/04TRANSCRIPT : Inogen, Inc., Q2 2022 Earnings Call, Aug 04, 2022
CI
08/04Earnings Flash (INGN) INOGEN Reports Q2 Revenue $103.4M
MT
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
08/08/2022 08/09/2022 08/10/2022 08/11/2022 08/12/2022 Date
27.61(c) 27.61(c) 28.19(c) 30.14(c) 30.57 Last
209 297 272 946 290 192 231 700 18 035 Volume
-0.36% 0.00% +2.10% +6.92% +1.43% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 374 M - -
Net income 2022 -37,1 M - -
Net cash position 2022 242 M - -
P/E ratio 2022 -18,6x
Yield 2022 -
Sales 2023 411 M - -
Net income 2023 -24,3 M - -
Net cash position 2023 270 M - -
P/E ratio 2023 -29,1x
Yield 2023 -
Capitalization 688 M 688 M -
EV / Sales 2022 1,19x
EV / Sales 2023 1,02x
Nbr of Employees 1 021
Free-Float 98,3%
More Financials
Company
Inogen, Inc. is a medical technology company, which provides respiratory products for use in the homecare setting. The Company primarily develops, manufactures, and markets portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One systems concentrate the air around the patient to offer a single source of supplemental... 
More about the company
Ratings of Inogen, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B
More Ratings
All news about INOGEN, INC.
08/04INOGEN : Q2 Earnings Snapshot
AQ
08/04TRANSCRIPT : Inogen, Inc., Q2 2022 Earnings Call, Aug 04, 2022
CI
08/04Earnings Flash (INGN) INOGEN Reports Q2 Revenue $103.4M
MT
08/04Earnings Flash (INGN) INOGEN Posts Q2 Loss $-0.02
MT
08/04INOGEN : Announces Second Quarter 2022 Financial Results - Form 8-K
PU
08/04INOGEN INC : Management's Discussion and Analysis of Financial Condition and Results of Op..
AQ
08/04Inogen Announces Second Quarter 2022 Financial Results
BU
08/04Inogen, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June ..
CI
07/07Inogen to Announce Second Quarter 2022 Financial Results on August 4, 2022
BU
06/24INOGEN, INC.(NASDAQGS : INGN) added to Russell 3000 Value Index
CI
06/24INOGEN, INC.(NASDAQGS : INGN) added to Russell Microcap Value Index
CI
06/24INOGEN, INC.(NASDAQGS : INGN) dropped from Russell 2000 Growth-Defensive Index
CI
06/24INOGEN, INC.(NASDAQGS : INGN) added to Russell 2000 Value Index
CI
06/24INOGEN, INC.(NASDAQGS : INGN) added to Russell Microcap Growth Index
CI
06/24INOGEN, INC.(NASDAQGS : INGN) added to Russell 3000E Index
CI
More news
News in other languages on INOGEN, INC.
08/04Earnings Flash (INGN) INOGEN annonce un chiffre d'affaires de 103,4 millions de dollars..
08/04Inogen, Inc. annonce ses résultats pour le deuxième trimestre et le semestre clos le 30..
05/18Inogen, Inc. nomme Agnes Lee au poste de vice-présidente principale des relations avec ..
05/05Earnings Flash (INGN) INOGEN annonce un chiffre d'affaires de 80,4 millions de dollars ..
05/05Inogen, Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2022
More news
Analyst Recommendations on INOGEN, INC.
More recommendations
Chart INOGEN, INC.
Duration : Period :
Inogen, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends INOGEN, INC.
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 5
Last Close Price 30,14 $
Average target price 35,67 $
Spread / Average Target 18,3%
EPS Revisions
Managers and Directors
Nabil Shabshab President, Chief Executive Officer & Director
Kristin A. Caltrider Treasurer, Chief Financial & Accounting Officer
Elizabeth A. Mora Chairman
Stanislav Glezer Chief Technology Officer
Bart Sanford Executive Vice President-Operations
Sector and Competitors
1st jan.Capi. (M$)
INOGEN, INC.-11.35%688
ABBOTT LABORATORIES-21.49%193 492
MEDTRONIC PLC-9.10%124 952
BECTON, DICKINSON AND COMPANY5.55%73 980
HOYA CORPORATION-17.18%38 478
SARTORIUS STEDIM BIOTECH-19.69%36 875